Koyfin Home > Directory > Health Care > Acorda Therapeutics > Cash Acquisitions

Acorda Therapeutics Cash Acquisitions Chart (ACOR)

Acorda Therapeutics annual/quarterly Cash Acquisitions from 2013 to 2016.
  • Acorda Therapeutics Cash Acquisitions for the quarter ending December 12, 2016 was $2m a 28,905.26% increase of 478m year over year
  • Acorda Therapeutics Cash Acquisitions for the last 12 months ending September 09, 2017 was $2m a 16,219.42% increase of 268m year over year
  • Acorda Therapeutics Annual Cash Acquisitions for 2016 was $-266m a -78.70% increase of 210m from 2015
  • Acorda Therapeutics Annual Cash Acquisitions for 2014 was $-476m a 98.43% decrease of -469m from 2013
  • Acorda Therapeutics Annual Cash Acquisitions for 2013 was $-7m
Other Cash Flow Metrics:
  • Acorda Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $78m a 23.00% increase of 18m year over year
  • Acorda Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $60m a 1.90% increase of 1m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Cash Acquisitions Data

12/2016$2m
09/2016$7m
06/2016$-275m
12/2014$-476m
12/2013$0m
09/2013$-7m

Annual ACOR Cash Acquisitions Data

2016$-266m
2014$-476m
2013$-7m